Categories:
50 years of Law No. 6,360/1976
This year marks 50 years since Law No. 6,360/1976 was enacted, the law that first established health
Read more
25 September: World Pharmacists Day
Today we celebrate World Pharmacists Day, a great moment to recognize the team that makes Vita happe
Read more
Do you know that Vita conducts systematic reviews in accordance with ANVISA Guide 61?
For synthetic and semisynthetic drug products, Resolutions RDC No. 753/2022 and RDC No. 948/2024 fro
Read more
ANVISA Holds Reliance Workshop in Brasília
On September 18, ANVISA held, in Brasília, the Reliance Workshop. The event was held in a hybrid fo
Read more
RDC 997/2025: Understanding the Resolution’s Impact and Developments in ANVISA’s Application Review
In November 2025, ANVISA published Resolution RDC No. 997, of November 7, 2025, which governs the ma
Read more
ANVISA approves pilot project for optimized quality review based on the REQ
On September 9, 2026, ANVISA published Normative Instruction (IN) No. 469/2026, which institutes the
Read more
Vita Participates: ANVISA Seminar on the New Regulatory Framework for Herbal Medicines
On August 28, Vita attended the seminar hosted by ANVISA in Brasília on the new regulatory requirem
Read more
ANVISA publishes IN 467/2026: List of qualified impurities and their respective limits in accordance with RDC No. 964, from February 20, 2025.
On August 26, 2026, ANVISA published Normative Instruction (IN) No. 467/2026, amending IN No. 258/20
Read more
ANVISA updates Q&A on relative bioavailability/bioequivalence studies (Resolution RDC No. 742/2022) – updated on 10/28/2026
Since August 2026, ANVISA has published three updates to its Questions and Answers document on Resol
Read more
ANVISA opens to contributions for the review of the regulatory framework for biological products
On August 20, 2026, Brazil’s Health Regulatory Agency (ANVISA) opened a technical contribution
Read more
ANVISA releases priority queues for GMP certification applications
Brazil’s Health Regulatory Agency (ANVISA) has begun publishing queues of Good Manufacturing P
Read more
ANVISA – new application form for GMP certification for advanced therapy medicinal products
On August 14, 2026, Brazil’s Health Regulatory Agency (ANVISA) released the new Good Manufactu
Read more